Supervised injection sites in prisons are not universally accepted by correctional officers.
Articles on Opioids
Displaying 21 - 40 of 222 articles
Veterinary drug medetomidine spreads through illicit opioid supply.
Kratom, an herbal product, is a remedy to some and a risk to others.
In recent years, the majority of stimulant-related overdose deaths have also involved fentanyl or other synthetic opioids.
A drug with antidepressant roots and opioid effects, tianeptine’s rise is largely unnoticed.
Incarcerating people who use drugs is associated with increased overdose deaths after release and high rate of recidivism.
Workplaces across the country are becoming safe and supportive places for people with substance use issues.
Doctors had believed that going over the maximum dose of one lifesaving drug could lead to more abuse. But after patients improved with one more pill, they convinced the FDA to change its guidelines.
People with back pain are increasingly accessing emergency health care that isn’t required and may leave them worse off.
Opioid overdoses are now complicated by a powerful animal tranquilliser.
Increasingly, these types of tranquilizers are turning up in fentanyl, oxycodone and other illegal opioids.
An emergency physician and nurse scientist explain what medetomidine is and how to respond if someone is overdosing on it.
Philly’s opioid addiction crisis is constantly evolving. Local health care workers and researchers explain some of the latest substances, side effects and treatments.
More than half of the street fentanyl samples collected in November 2024 contained BTMPS, and many contained more BTMPS than fentanyl.
After nearly a decade of annual upticks in overdose deaths, the city saw a drop in 2023, the latest data available. Something may finally be working − but what?
Opioids and other addictive drugs can alter the rhythmic activity of genes involved in sleep-wake cycles.
Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.
The FDA has approved suzetrigine, a groundbreaking non-opioid painkiller that targets pain at its source, offering a safer, addiction-free pain-relief treatment.
Tariffs may sound tough, but America’s fentanyl crisis stems from a decades-long addiction problem that trade policy can’t fix.
The study offers insight into how marijuana access may alter treatment patterns for patients with anxiety.
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Professor, Institute for Musculoskeletal Health, University of Sydney
-
Professor of Neuropharmacology, University of Lancashire
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Professor, Sydney School of Public Health, University of Sydney
-
Medical Director of Opioid Policy Research, Brandeis University
-
Professor of Geography, Penn State
-
Associate Professor of Sociology, Bentley University
-
Associate Professor of Emergency Medicine, Thomas Jefferson University
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Associate Professor, School of Public Health, University of Sydney
-
Professor of Law, Indiana University
-
Senior Lecturer in Criminology, UNSW
-
Professor, National Drug Research Institute, Curtin University and Burnet Institute, Burnet Institute